Hologic to Present at the Nasdaq OMX 27th Investor Program in London

BEDFORD, Mass., Dec. 1, 2011 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) today announced that Glenn Muir, Executive Vice President and Chief Financial Officer, will be presenting at the Nasdaq OMX 27th Investor Program in London on Tuesday, December 6, 2011, at 11:15am (GMT).

Interested parties are invited to listen to the live audio webcast of the investor presentation on the investor section of Hologic's website at www.hologic.com/investors-overview. An archive of the presentation will be available for replay following the conferences.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, breast Magnetic Resonance Imaging, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia and uterine fibroids, permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications. For more information, visit www.hologic.com.


Contact:

Deborah Gordon
Vice President, Investor Relations
Hologic, Inc.
(781) 999-7716

 

 

SOURCE Hologic, Inc.